upadacitinibelsubrutinibSLE
…eceiving upadacitinib, upadacitinib/elsubrutinib and placebo to upadacitinib/elsubrutinib were maintained or increased from weeks 48 to 104 …
2articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: elsubrutinib ×
elsubrutinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning elsubrutinib
2 articles · page 1 of 1deucravacitinibianalumabupadacitinibtelitaciceptBaricitinibelsubrutinibsystemic lupus erythematosus
…oral small molecule kinase inhibitors, such as upadacitinib and deucravacitinib, as potential additions to standard of care in SLE, considering…